Anti-oncogenic effects of dutasteride, a dual 5-alpha reductase inhibitor and a drug for benign prostate hyperplasia, in bladder cancer

BACKGROUND: The incidence of bladder cancer (BCa) is approximately four times higher in men than in women. To develop effective BCa treatments, there is an urgent need to understand the differences in the BCa control mechanisms based on gender. Our recent clinical study showed that androgen suppress...

Descripción completa

Detalles Bibliográficos
Autores principales: Seok, Jaekwon, Kwak, Hee Jeong, Kwak, Yeonjoo, Lee, Moonjung, Park, Kyoung Sik, Kim, Aram, Cho, Ssang-Goo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938606/
https://www.ncbi.nlm.nih.gov/pubmed/36800968
http://dx.doi.org/10.1186/s12967-023-03972-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938606/
https://www.ncbi.nlm.nih.gov/pubmed/36800968
http://dx.doi.org/10.1186/s12967-023-03972-4

Ejemplares similares